Drug intelligence / Profile preview

Xiaoding cream

Development stage: Unknown
Lead developer: Gansu Provincial Hospital of Traditional Chinese Medicine
Administration: Topical

Overview

Xiaoding cream is a traditional Chinese medicine (TCM) topical formulation developed by the Gansu Provincial Hospital of Traditional Chinese Medicine. It is specifically indicated for the management of localized complications arising from arteriovenous fistula (AVF) punctures in patients undergoing hemodialysis, including swelling, subcutaneous hematoma, and associated pain. The cream is applied externally to the affected area to promote blood circulation, resolve stasis, and alleviate inflammatory symptoms. It is currently under clinical investigation to assess its efficacy in improving vascular access site recovery and patient comfort during dialysis.

Other names: Xiaoding ointmentanti-demobilization ointment

Beyond the preview

Go deeper on Xiaoding cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoding cream.

Explore the full profile